PRZOOM - /newswire/ -
Delhi, New Delhi, India, 2007/04/17 - Studies of stem cell will largely contribute to the future of cardiovascular research, as it offers immense scope to develop regenerative therapy for cardiovascular diseases.
Cardiovascular research’s future is entailed in the studies of stem cell. As, it offers tremendous scope for developing regenerative therapy for cardiovascular diseases, said M.S. Valiathan, Professor and Honorary Advisor for Manipal Academy of Higher Education & National Research in a statement that THE HINDU published on 2 February 2007.
Reportedly, Dr. Valiathan said this while inaugurating the three-day seminar on Cardiovascular Prosthetic Devices. The Indo-US Science & Technology Forum, New Delhi, and Sree Chitra Tirunal Institute for Medical Sciences jointly organized this workshop in Thiruvananthapuram on 1st February 2007.
Besides reinforcing cardiovascular research, stem cell therapy can bring in radical transformation in the treatment of various diseases in humans, according to medical researchers. There are several stem cell therapies presently in practice, specifically the bone marrow transplants.
Indian Council for Medical Research in its estimates revealed that about three to six of every 1,000 children in India are susceptible to rheumatic heart diseases and need valve replacement. Although nearly 50 million Indians have coronary artery diseases, only 25,000-40,000 surgical & interventional procedures take place per annum.
In spite of evidently huge requirement, there’s an incessant import of almost 80% of all biomedical devices in this country. Also, the R&D in stem cell is also limited to select centers here.
However, the country is drafting plans for a countrywide stem cell program in order to enhance stem cell research’s clinical applications, construct bridges between medical doctors and scientists and prioritize research-funding areas.
The purpose of designing this Indo-US workshop was to highlight the areas of research encompassing the experimental, animal as well as human trials for cardiovascular implants, particularly stents & prosthetic heart valves.
As per the RNCOS report “Indian Biotechnology Market Outlook (2006)”, India will soon emerge as a hub for stem cell research as well as clinical trials. Indian biotechnology industry, with growth rate being 28.9% since 2005, will likely touch US$ 5 Billion mark by the year-end 2010.
This research report on “Indian Biotechnology Market Outlook (2006)” addresses some interesting issues for today’s global business environment. The issues it covers include market trends in the Indian Biotechnology industry, where the market will be after five years, opportunities that exist in Indian Biotechnology industry, driving factors for the Indian Biotechnology industry, challenges faced by Biotechnology industry, and key players in the Indian Biotechnology industry.
About RNCOS E-Services Pvt Ltd
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.